V10XA01
— Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Sodium iodide (131I) is a radioactive compound used in the treatment and diagnosis of thyroid conditions such as hyperthyroidism and thyroid cancer. It emits radiation that destroys overactive or cancerous thyroid cells.
It is administered orally, in capsule or solution form, and is quickly absorbed by the thyroid gland. Treatment with Sodium iodide (131I) is effective and minimally invasive, serving as an alternative to surgical interventions.
Side effects may include dry mouth, fatigue, or inflammation of the salivary glands. As a radioactive compound, its use requires special precautions to minimize radiation exposure.
Consult your doctor to discuss the benefits and risks of treatment with Sodium iodide (131I). It is important to follow all instructions to ensure the safety and effectiveness of the treatment.
General data about FID-NA-131-I-T 37-5500 MBq
Substance:
sodium iodide (131I)
Date of latest medicines list:
01-10-2026
Product code:
W66052008
Strength:
37-5500MBq
Pharmaceutical form:
capsules for therapeutic use
Quantity:
1
Product type:
Generic medicine
Price:
1857.04 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Marketing authorisation
Manufacturer:
NATIONAL CENTRE FOR NUCLEAR RESEARCH - POLONIA
Holder:
S.C. FIDELIO FARM SRL - ROMANIA
Number:
11768/2019/01
Shelf life:
21 days
Pharmaceutical forms available for sodium iodide (131I)